Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Halperin

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Cancer|April 2, 2020
Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapyHamzah Abu-Sbeih, Niharika Mallepally, Ryan Goldstein, et al.
Pharmacoeconomics|April 24, 2018
Costs of Cancer Care for Elderly Patients with Neuroendocrine TumorsChan Shen, Arvind Dasari, Dian Gu, et al.
Circulation. Genomic and Precision Medicine|December 21, 2018
Nocturnal Atrial Fibrillation Caused by Mutation in KCND2, Encoding Pore-Forming (α) Subunit of the Cardiac Kv4.2 Potassium ChannelMax Drabkin, Noam Zilberberg, Sasson Menahem, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Trials|May 2, 2024
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
The Journal of Clinical Investigation|October 23, 2019
Hyperuricemia and gout caused by missense mutation in d-lactate dehydrogenaseMax Drabkin, Yuval Yogev, Lior Zeller, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Aryl hydrocarbon receptor restricts axon regeneration of DRG neurons in response to injuryDalia Halawani, Yiqun Wang, Molly Estill, et al.
Molecular Diagnosis & Therapy|July 7, 2022
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 MyopathyYuval Yogev, Jacob Bistritzer, Yair Sadaka, et al.
Nature|April 1, 2026
AhR inhibition promotes axon regeneration via a stress-growth switchDalia Halawani, Yiqun Wang, Jiaxi Li, et al.
Clinical Genetics|April 20, 2022
A syndrome of severe intellectual disability, hypotonia, failure to thrive, dysmorphism, and thinning of corpus callosum maps to chromosome 7q21.13-q21.3Daniel Halperin, Nadav Agam, Maher Hallak, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cancer|April 2, 2020
Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapyHamzah Abu-Sbeih, Niharika Mallepally, Ryan Goldstein, et al.
Pharmacoeconomics|April 24, 2018
Costs of Cancer Care for Elderly Patients with Neuroendocrine TumorsChan Shen, Arvind Dasari, Dian Gu, et al.
Circulation. Genomic and Precision Medicine|December 21, 2018
Nocturnal Atrial Fibrillation Caused by Mutation in KCND2, Encoding Pore-Forming (α) Subunit of the Cardiac Kv4.2 Potassium ChannelMax Drabkin, Noam Zilberberg, Sasson Menahem, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Trials|May 2, 2024
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
The Journal of Clinical Investigation|October 23, 2019
Hyperuricemia and gout caused by missense mutation in d-lactate dehydrogenaseMax Drabkin, Yuval Yogev, Lior Zeller, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Aryl hydrocarbon receptor restricts axon regeneration of DRG neurons in response to injuryDalia Halawani, Yiqun Wang, Molly Estill, et al.
Molecular Diagnosis & Therapy|July 7, 2022
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 MyopathyYuval Yogev, Jacob Bistritzer, Yair Sadaka, et al.
Nature|April 1, 2026
AhR inhibition promotes axon regeneration via a stress-growth switchDalia Halawani, Yiqun Wang, Jiaxi Li, et al.
Clinical Genetics|April 20, 2022
A syndrome of severe intellectual disability, hypotonia, failure to thrive, dysmorphism, and thinning of corpus callosum maps to chromosome 7q21.13-q21.3Daniel Halperin, Nadav Agam, Maher Hallak, et al.
Pageof 6